Dominant unit CD34+ cell dose predicts engraftment after double-unit cord blood transplantation and is influenced by bank practice

Blood

Volumn 124, Issue 19, 2014, Pages 2905-2912

  Purtill, Duncan ^a   Smith, Katherine ^a   Devlin, Sean ^a   Meagher, Richard ^a   Tonon, Joann ^a   Lubin, Marissa ^a   Ponce, Doris M ^a,b   Giralt, Sergio ^a,b   Kernan, Nancy A ^a   Scaradavou, Andromachi ^a   Stevens, Cladd E ^a   Barker, Juliet N ^a,b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; BIOLOGICAL MARKER;

ARTICLE; BLOOD BANK; CANCER INCIDENCE; CELL COUNT; CELL VIABILITY; CHILD; COLONY FORMING UNIT; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; CRYOPRESERVATION; DOUBLE UNIT CORD BLOOD TRANSPLANTATION; ENGRAFTMENT; HUMAN; INFANT; MAJOR CLINICAL STUDY; NEUTROPHIL COUNT; NEWBORN; ADOLESCENT; ADULT; AGED; BLOOD STORAGE; CELL SEPARATION; COMPARATIVE STUDY; GRAFT SURVIVAL; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; METABOLISM; MIDDLE AGED; NEUTROPHIL; PRESCHOOL CHILD; PROCEDURES; TRANSPLANTATION; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANTIGENS, CD34; BIOLOGICAL MARKERS; BLOOD BANKS; BLOOD PRESERVATION; CELL SEPARATION; CHILD; CHILD, PRESCHOOL; CORD BLOOD STEM CELL TRANSPLANTATION; CRYOPRESERVATION; GRAFT SURVIVAL; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; MIDDLE AGED; NEUTROPHILS; YOUNG ADULT;

EID: 84909595177     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2014-03-566216     Document Type: Article

References (42)

1. Brunstein CG, Gutman JA, Weisdorf DJ, et al. Allogeneic hematopoietic cell transplantation for hematologic malignancy: relative risks and benefits of double umbilical cord blood. Blood. 2010;116(22):4693-4699.
2. Eapen M, Rocha V, Sanz G, et al; Center for International Blood and Marrow Transplant Research; Acute Leukemia Working Party Eurocord (the European Group for Blood Marrow Transplantation); National Cord Blood Program of the New York Blood Center. Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis. Lancet Oncol. 2010;11(7):653-660.
3. Ponce DM, Zheng J, Gonzales AM, et al. Reduced late mortality risk contributes to similar survival after double-unit cord blood transplantation compared with related and unrelated donor hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2011;17(9):1316-1326.
4. Atsuta Y, Morishima Y, Suzuki R, et al; Japan Marrow Donor Program and Japan Cord Blood Bank Network. Comparison of unrelated cord blood transplantation and HLA-mismatched unrelated bone marrow transplantation for adults with leukemia. Biol Blood Marrow Transplant. 2012;18(5):780-787.
5. Chen YB, Aldridge J, Kim HT, et al. Reducedintensity conditioning stem cell transplantation: comparison of double umbilical cord blood and unrelated donor grafts. Biol Blood Marrow Transplant. 2012;18(5):805-812.
6. Wagner JE, Barker JN, DeFor TE, et al. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood. 2002;100(5):1611-1618.
7. Barker JN, Scaradavou A, Stevens CE. Combined effect of total nucleated cell dose and HLA match on transplantation outcome in 1061 cord blood recipients with hematologic malignancies. Blood. 2010;115(9):1843-1849.
8. Barker JN, Weisdorf DJ, DeFor TE, et al. Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy. Blood. 2005;105(3):1343-1347.
9. Scaradavou A, Brunstein CG, Eapen M, et al. Double unit grafts successfully extend the application of umbilical cord blood transplantation in adults with acute leukemia. Blood. 2013;121(5):752-758.
10. Delaney C, Heimfeld S, Brashem-Stein C, Voorhies H, Manger RL, Bernstein ID. Notchmediated expansion of human cord blood progenitor cells capable of rapid myeloid reconstitution. Nat Med. 2010;16(2):232-236.
11. de Lima M, McNiece I, Robinson SN, et al. Cordblood engraftment with ex vivo mesenchymal-cell coculture. N Engl J Med. 2012;367(24):2305-2315.
12. Cutler C, Multani P, Robbins D, et al. Prostaglandin-modulated umbilical cord blood hematopoietic stem cell transplantation. Blood. 2013;122(17):3074-3081.
13. Bautista G, Cabrera JR, Regidor C, et al. Cord blood transplants supported by co-infusion of mobilized hematopoietic stem cells from a thirdparty donor. Bone Marrow Transplant. 2009;43(5):365-373.
14. Van Besien K, Liu H, Jain N, Stock W, Artz A. Umbilical cord blood transplantation supported by third-party donor cells: rationale, results, and applications. Biol Blood Marrow Transplant. 2013;19(5):682-691.
15. Gluckman E, Rocha V, Boyer-Chammard A, et al; Eurocord Transplant Group and the European Blood and Marrow Transplantation Group. Outcome of cord-blood transplantation from related and unrelated donors. N Engl J Med. 1997;337(6):373-381.
16. Rubinstein P, Carrier C, Scaradavou A, et al. Outcomes among 562 recipients of placentalblood transplants from unrelated donors. N Engl J Med. 1998;339(22):1565-1577.
17. Laughlin MJ, Barker J, Bambach B, et al. Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. N Engl J Med. 2001;344(24):1815-1822.
18. Migliaccio AR, Adamson JW, Stevens CE, Dobrila NL, Carrier CM, Rubinstein P. Cell dose and speed of engraftment in placental/umbilical cord blood transplantation: graft progenitor cell content is a better predictor than nucleated cell quantity. Blood. 2000;96(8):2717-2722.
19. Sanz J, Sanz MA, Saavedra S, et al. Cord blood transplantation from unrelated donors in adults with high-risk acute myeloid leukemia. Biol Blood Marrow Transplant. 2010;16(1):86-94.
20. Page KM, Zhang L, Mendizabal A, et al. Total colony-forming units are a strong, independent predictor of neutrophil and platelet engraftment after unrelated umbilical cord blood transplantation: a single-center analysis of 435 cord blood transplants. Biol Blood Marrow Transplant. 2011;17(9):1362-1374.
21. Sanz G, Lorenzo I, Moscardo F, et al. Outcome and prognostic factors after unrelated donor umbilical cord blood transplantation in adult patients with hematologic malignancies transplanted in early disease stages. ASH Annu Mtg Abstr. 2004;104(11):2149.
22. Moroff G, Eichler H, Brand A, et al; Biomedical Excellence for Safer Transfusion (BEST) Collaborative. Multiple-laboratory comparison of in vitro assays utilized to characterize hematopoietic cells in cord blood. Transfusion. 2006;46(4):507-515.
23. Spellman S, Hurley CK, Brady C, et al; National Marrow Donor Program Cord Blood Advisory Group. Guidelines for the development and validation of new potency assays for the evaluation of umbilical cord blood. Cytotherapy. 2011;13(7):848-855.
24. Scaradavou A, Smith KM, Hawke R, et al. Cord blood units with low CD341 cell viability have a low probability of engraftment after double unit transplantation. Biol Blood Marrow Transplant. 2010;16(4):500-508.
25. Avery S, Shi W, Lubin M, et al. Influence of infused cell dose and HLA match on engraftment after double-unit cord blood allografts. Blood. 2011;117(12):3277-3285, quiz 3478.
26. Rodríguez L, García J, Querol S. Predictive utility of the attached segment in the quality control of a cord blood graft. Biol Blood Marrow Transplant. 2005;11(4):247-251.
27. Ponce DM, Sauter C, Devlin S, et al. A novel reduced-intensity conditioning regimen induces a high incidence of sustained donor-derived neutrophil and platelet engraftment after doubleunit cord blood transplantation. Biol Blood Marrow Transplant. 2013;19(5):799-803.
28. Barker JN, Abboud M, Rice RD, et al. A "no-wash" albumin-dextran dilution strategy for cord blood unit thaw: high rate of engraftment and a low incidence of serious infusion reactions. Biol Blood Marrow Transplant. 2009;15(12):1596-1602.
29. Ponce DM, Gonzales A, Lubin M, et al. Graftversushost disease after double-unit cord blood transplantation has unique features and an association with engrafting unit-to-recipient HLA match. Biol Blood Marrow Transplant. 2013;19(6):904-911.
30. Avery S, Voss MH, Gonzales AM, et al. Importance of day 21 BM chimerism in sustained neutrophil engraftment following double-unit cord blood transplantation. Bone Marrow Transplant. 2012;47(8):1056-1060.
31. Barker JN, Byam C, Scaradavou A. How I treat: the selection and acquisition of unrelated cord blood grafts. Blood. 2011;117(8):2332-2339.
32. Eldjerou LK, Chaudhury S, Baisre-de Leon A, et al. An in vivo model of double-unit cord blood transplantation that correlates with clinical engraftment. Blood. 2010;116(19):3999-4006.
33. Gutman JA, Turtle CJ, Manley TJ, et al. Singleunit dominance after double-unit umbilical cord blood transplantation coincides with a specific CD81 T-cell response against the nonengrafted unit. Blood. 2010;115(4):757-765.
34. Milano F, Heimfeld S, Gooley T, Jinneman J, Nicoud I, Delaney C. Correlation of infused CD31 CD81 cells with single-donor dominance after double-unit cord blood transplantation. Biol Blood Marrow Transplant. 2013;19(1):156-160.
35. Van Haute I, Lootens N, De Smet S, et al. Viable CD341 stem cell content of a cord blood graft: which measurement performed before transplantation is most representative? Transfusion. 2004;44(4):547-554.
36. Flores AI, McKenna DH, Montalbán MA, De la Cruz J, Wagner JE, Bornstein R. Consistency of the initial cell acquisition procedure is critical to the standardization of CD341 cell enumeration by flow cytometry: results of a pairwise analysis of umbilical cord blood units and cryopreserved aliquots. Transfusion. 2009;49(4):636-647.
37. Hunt CJ, Armitage SE, Pegg DE. Cryopreservation of umbilical cord blood:2. Tolerance of CD34 (1) cells to multimolar dimethyl sulphoxide and the effect of cooling rate on recovery after freezing and thawing. Cryobiology. 2003;46(1):76-87.
38. Rubinstein P, Dobrila L, Rosenfield RE, et al. Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution. Proc Natl Acad Sci USA. 1995;92(22):10119-10122.
39. M-Reboredo N, Díaz A, Castro A, Villaescusa RG. Collection, processing and cryopreservation of umbilical cord blood for unrelated transplantation. Bone Marrow Transplant. 2000;26(12):1263-1270.
40. Bone Marrow Donors Worldwide. www.bmdw.org. Accessed January 27, 2014.
41. Rocha V, Gluckman E; Eurocord-Netcord registry and European Blood and Marrow Transplant group. Improving outcomes of cord blood transplantation: HLA matching, cell dose and other graft- and transplantation-related factors. Br J Haematol. 2009;147(2):262-274.
42. Ponce DM, Lubin M, Gonzales AM, et al. The use of back-up units to enhance the safety of unrelated donor cord blood transplantation. Biol Blood Marrow Transplant. 2012;18(4):648-651.